𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiparkinsonian Effects of Novel Adenosine A2A Receptor Antagonists

✍ Scribed by Anna Drabczyńska; Małgorzata Zygmunt; Jacek Sapa; Barbara Filipek; Christa E. Müller; Katarzyna Kieć-Kononowicz

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
209 KB
Volume
344
Category
Article
ISSN
0365-6233

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SCH 58261: A selective A2A adenosine rec
SCH 58261: A selective A2A adenosine receptor antagonists
✍ Ennio Ongini 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

The recent discovery of selective antagonists for the A 2A adenosine receptors has been of great help to further research in this field. One compound, SCH 58261, 5-amino-7-(β-phenylethyl)-2-(8furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine, is playing a key part in a variety of studies. This r

Comparative molecular field analysis (Co
Comparative molecular field analysis (CoMFA) of a series of selective adenosine receptor A2A antagonists
✍ Pier Giovanni Baraldi; Pier Andrea Borea; Manuela Bergonzoni; Barbara Cacciari; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB 👁 1 views

Selective and potent antagonists for the A 2A adenosine receptors have been described recently. The most potent compounds have a triazolo-pyrimidine structure, whereas 8-styryl-xanthines usually possess lower affinity at the A 2A receptor. We have examined the quantitative structure activity relatio

A3 adenosine receptors: Protective vs. d
A3 adenosine receptors: Protective vs. damaging effects identified using novel agonists and antagonists
✍ Kenneth A. Jacobson; Stefano Moro; Yong-Chul Kim; An-Hu Li 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 1 views

Investigation of the physiologic role of the A 3 adenosine receptor has been facilitated by the availability of selective agonists and antagonists. Selective agonists include IB-MECA and the 2-chloro derivative Cl-IB-MECA. Selective antagonists have been identified and designed with the aid of molec

Potent antagonists for the human adenosi
Potent antagonists for the human adenosine A2B receptor. Derivatives of the triazolotriazine adenosine receptor antagonist ZM241385 with high affinity
✍ Maarten de Zwart; Roel C. Vollinga; Margot W. Beukers; Danielle F. Sleegers; Jac 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

A series of novel and known 5-substituted 7-amino-2-(2-furyl) [1,2,4]triazolo [1,5a][1,3,5]triazine derivatives were synthesized and tested for adenosine receptor antagonism in radioligand binding assays at all four adenosine receptor subtypes and for inhibition of the agonist-induced cyclic AMP res

Pyran template approach to the design of
Pyran template approach to the design of novel A3 adenosine receptor antagonists
✍ An-Hu Li; Xiao-duo Ji; Hak Sung Kim; Neli Melman; Kenneth A. Jacobson 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

A 3 adenosine receptor antagonists have potential as anti-inflammatory, anti-asthmatic, and anti-ischemic agents. We previously reported the preparation of chemical libraries of 1,4-dihydropyridine (DHP) and pyridine derivatives and identification of members having high affinity at A 3 adenosine rec

A2A-selective adenosine receptor antagon
A2A-selective adenosine receptor antagonists: Development of water-soluble prodrugs and a new tritiated radioligand
✍ Christa E. Müller; Roland Sauer; Yuris Maurinsh; Rosa Huertas; Friederike Fülle; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 1 views

A 2A adenosine receptor (AR) antagonists are promising new drugs for the treatment of Parkinson's disease. Further potential therapeutic indications for A 2A AR antagonists include dementias, ischemias, and pain. Potent, selective A 2A AR antagonists have been developed, but their generally low wate